The impact of cycleanine in cancer research: a computational study
Cancer is imposing a global health burden because of the steady increase in new cases. Moreover, current anticancer therapeutics are associated with many drawbacks, mainly the emergence of resistance and the severe adverse effects. Therefore, there is a continuous need for developing new anticancer...
Main Authors: | Nwaefulu, Ogochukwu Ngozi, Al-Shar'i, Nizar A, Owolabi, Josephine Omonkhelin, Sagineedu, Sreenivasa Rao, Lim, Chee Woei, Lam, Kok Wai, Islam, Mohammad Kaisarul, Jayanthi, Sivaraman, Stanslas, Johnson |
---|---|
Format: | Article |
Published: |
Springer
2022
|
Similar Items
-
Pancreatic cancer treatment with targeted therapies: are we there yet
by: Nwaefulu, O. Ngozi, et al.
Published: (2022) -
Pharmacological modulation of apoptosis and autophagy in pancreatic cancer treatment
by: Stanslas, Johnson, et al.
Published: (2022) -
Ethnobotanical study of anticancer plants used in Ugbine, Nigeria and bioactivity-guided isolation of cytotoxic agents from Synclisia scabrida (Miers) ex oliv
by: Ngozi, Nwaefulu Ogochukwu
Published: (2022) -
SRS06, a new semisynthetic andrographolide derivative with improved anticancer potency and selectivity, inhibits nuclear factor-kB nuclear binding in the A549 non-small cell lung cancer cell line
by: Lim, Jonathan Chee Woei, et al.
Published: (2015) -
Advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents
by: Soo, Hon Liong, et al.
Published: (2019)